Xiaomi is set to resume sales of its devices in India, following a bar imposed by the Delhi High Court related to patent licensing issues.
Hugo Barra, international VP for the vendor, said that the same court has now “issued a ruling in our favour, allowing us to resume sales to India subject to certain terms”.
According to The Hindu, this means that devices powered by Qualcomm chipsets are clear to go back on sale, because the US silicon vendor has a deal in place with Swedish infrastructure giant Ericsson, which initiated the dispute.
Other sources indicate that devices powered by Chinese silicon vendor MediaTek are still verboten, meaning that the RedMi Note phablet will remain unavailable (although the Qualcomm-powered 4G version will be back).
Xiaomi is not having it all its own way, though. The company is having to deposit INR100 ($1.57) per handset sold in lieu of royalties, as well as providing details of units sold and the details of the Qualcomm deal.
Ericsson turned to the courts after Xiaomi failed to respond to six requests for royalties, according to reports.
With Xiaomi’s margins already wafer-thin, according to reports, additional costs are hardly likely to be welcomed.